Your browser doesn't support javascript.
loading
2-Oxoquinoline-based-thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors.
Basri, Rabia; Fatima, Shamool; Jalil, Saquib; Imran, Aqeel; Fatima, Noor; Syed, Asad; Bahkali, Ali H; Iqbal, Jamshed; Shafiq, Zahid.
Afiliação
  • Basri R; Institute of Chemical Sciences, Bahauddin Zakariya University, Multan, Pakistan.
  • Fatima S; Department of Chemistry, Quaid-i-Azam University, Islamabad, Pakistan.
  • Jalil S; Centre for Advanced Drug Research, COMSATS University Islamabad, Abbottabad Campus, Abbottabad, Pakistan.
  • Imran A; Centre for Advanced Drug Research, COMSATS University Islamabad, Abbottabad Campus, Abbottabad, Pakistan.
  • Fatima N; Department of Pharmacy, COMSATS University Islamabad, Lahore Campus, Islamabad, Punjab, Pakistan.
  • Syed A; Department of Chemistry, Quaid-i-Azam University, Islamabad, Pakistan.
  • Bahkali AH; Department of Botany and Microbiology, King Saud University, Riyadh, Saudi Arabia.
  • Iqbal J; Department of Botany and Microbiology, King Saud University, Riyadh, Saudi Arabia.
  • Shafiq Z; Centre for Advanced Drug Research, COMSATS University Islamabad, Abbottabad Campus, Abbottabad, Pakistan.
Arch Pharm (Weinheim) ; 356(11): e2300430, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37718357
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiossemicarbazonas / Quinolonas / Doença de Alzheimer Limite: Humans Idioma: En Revista: Arch Pharm (Weinheim) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Paquistão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiossemicarbazonas / Quinolonas / Doença de Alzheimer Limite: Humans Idioma: En Revista: Arch Pharm (Weinheim) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Paquistão